UK guidelines for the management of bone sarcomas
C Gerrand, F Amary, HA Anwar, B Brennan… - British Journal of …, 2024 - nature.com
This document is an update of the British Sarcoma Group guidelines (2016) and provides a
reference standard for the clinical care of UK patients with primary malignant bone tumours …
reference standard for the clinical care of UK patients with primary malignant bone tumours …
Ablative and immunostimulatory effects of histotripsy ablation in a murine osteosarcoma model
Background: Osteosarcoma (OS) is the most frequently occurring malignant bone tumor in
humans, primarily affecting children and adolescents. Significant advancements in treatment …
humans, primarily affecting children and adolescents. Significant advancements in treatment …
Do children with Osteosarcoma benefit from Pulmonary Metastasectomy?-A Systematic Review Of Published Studies and 'Real world'Outcomes
T Boam, BG Rogoyski, W Jawaid, PD Losty - Annals of Surgery, 2024 - journals.lww.com
Objective: To critically examine the evidence-base for survival benefit of Pulmonary
metastasectomy (PM) for Osteosarcoma (OS) in the paediatric population. Summary …
metastasectomy (PM) for Osteosarcoma (OS) in the paediatric population. Summary …
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients
Simple Summary Pediatric patients with recurrent and metastatic cancers often present with
substantial tumor and symptom burden. Local control is an important factor to consider in …
substantial tumor and symptom burden. Local control is an important factor to consider in …
[HTML][HTML] Clinical Outcomes of Carbon Ion Radiation Therapy for Malignant Peripheral Nerve Sheath Tumors
MR Fiore, A Chalaszczyk, A Barcellini, V Vitolo… - Advances in Radiation …, 2024 - Elsevier
Purpose To investigate the outcome and toxicity of patients affected by malignant peripheral
nerve sheath tumors (MPNSTs) treated with high-dose carbon ion radiation therapy (CIRT) …
nerve sheath tumors (MPNSTs) treated with high-dose carbon ion radiation therapy (CIRT) …
[HTML][HTML] Mechanisms of Cancer Cell Radioresistance: Modern Trends and Research Prospects
MG Sharapov, EE Karmanova, SV Gudkov - Biofizika, 2024 - journal-vniispk.ru
Radiation therapy holds a key position in the arsenal of cancer treatment methods. This non-
invasive technique has been actively used for several decades and has demonstrated high …
invasive technique has been actively used for several decades and has demonstrated high …
Stereotactic Ablative Radiation Therapy (SABR) for Adolescent and Young Adult Malignancies
R Singh, S Bishop, J Jenkins, J Davis, R Upadhyay… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background: There are limited studies examining local control (LC) and overall survival (OS)
following stereotactic ablative radiation therapy (SABR) for adolescent and young adult …
following stereotactic ablative radiation therapy (SABR) for adolescent and young adult …
[PDF][PDF] Vil bensarkomer være aktuelle kandidater for protonbehandling i Norge?
ED Holm, GL Larsen - 2024 - ntnuopen.ntnu.no
Hensikt: I denne studien sammenlignes de to strålebehandlingsmetodene for å undersøke
om stråleterapi er et godt behandlingsalternativ for bensarkomer, med fokus på akutte og …
om stråleterapi er et godt behandlingsalternativ for bensarkomer, med fokus på akutte og …
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy (LITE-SABR) for Recurrent and/or Metastatic Pediatric Cancers
Background: Pediatric, adolescents and young adults with metastatic and/or recurrent solid
tumors have poor survival outcomes. Multiagent systemic therapy is the mainstay of …
tumors have poor survival outcomes. Multiagent systemic therapy is the mainstay of …